Recent News

Bladder Drug Manufacturers Face Lawsuits Over Retinal Damage Linked to Elmiron

On Wednesday, August 12th, women in two separate complaints filed suit against units of Johnson & Johnson, Bayer and Teva Pharmaceuticals USA Inc. after they developed eye damage after taking bladder medication Elmiron. Here, the pharmaceutical liability attorneys at Peter Angelos P.C. discuss the latest updates in Elmiron litigation and what it means for patients…

Read More...

Talc-Based Johnson & Johnson Products Linked to Ovarian Cancer and Mesothelioma

Lawsuits against Johnson & Johnson continue to increase amid claims that talc-based J&J products may cause cancer. If you or someone you know has been diagnosed with ovarian cancer or mesothelioma after using Johnson & Johnson’s talc-based products, such as Baby Powder or Shower to Shower, do not hesitate to seek out legal counsel to…

Read More...

Elmiron Update: Warnings Changed to Include Risk of Eye Damage

On June 16th, 2020,  the Food and Drug Administration (FDA) announced labeling changes to Elmiron, a popular anticoagulant that is commonly prescribed to treat bladder pain caused by interstitial cystitis and osteoarthritis. Here, the pharmaceutical liability attorneys at Peter Angelos P.C. discuss the potential dangers to consumers taking Elmiron, and how to seek legal representation…

Read More...

Elmiron Linked to Vision Loss

Elmiron is a popular anticoagulant that is commonly prescribed to treat bladder pain caused by interstitial cystitis and osteoarthritis. Recently, Elmiron has been linked to the increased risk of pigmentary maculopathy and other forms of vision loss and damage. The pharmaceutical liability attorneys at Peter Angelos P.C. Law are actively investigating cases regarding the use…

Read More...

FDA Requests Removal of Zantac From the Market Immediately

On April 1st, the Food and Drug Administration (FDA) announced its request for all prescription and over-the-counter ranitidine drugs to be removed from the market immediately. This decision was made based on an ongoing investigation of possible carcinogenic effects of the contaminant N-nitrosodimethylamine, or NDMA. Here, the pharmaceutical liability attorneys at Peter Angelos, P.C. discuss…

Read More...

Continuation of Monsanto Dicamba Litigation Updates

In August 2019, environmentally conscious public-interest organizations filed a lawsuit against the U.S. Environmental Protection Agency and agrochemical company, Monsanto, after the approval of a pesticide meant for use on soybean and cotton plants. Here, the environmental litigation attorneys at Peter Angelos P.C. discuss the controversy surrounding the damaging dicamba pesticide and how the EPA’s…

Read More...

Juul Facing Litigation Concerning Death of 18-Year-Old

Amidst the growing litigation against Juul Labs, the e-cigarette powerhouse is now facing a lawsuit in regards to the death of an 18-year old Florida teenager who died after using vaping devices. Here, the attorneys at Peter Angelos, P.C. detail recent updates to ongoing Juul litigation and as well as insights to the first major…

Read More...

Zantac Manufacturer Recalls Medication Due to Confirmed Contamination

Sandoz Inc. has voluntarily recalled the generic version of common medication Zantac after the medication was confirmed to be contaminated with a human carcinogen. Here, the pharmaceutical liability attorneys at The Law Offices of Peter Angelos discuss the updates to the ongoing Zantac claims.  Global health regulators recently raised concerns about the possibility that the…

Read More...

Carcinogen Found in Stomach Drug Leads to Halt in Distribution

Global health regulators have raised the alarm about the possibility that the widely used drug, Zantac, could be tainted with the same cancer-causing agent found in Valsartan earlier this year. Here, the pharmaceutical liability attorneys at The Law Offices of Peter Angelos detail the preliminary results of the FDA and EU probes. Officials are Investigating…

Read More...

White House to Ban Flavored E-Cigarettes

The Trump Administration has asked that the Food and Drug Administration (FDA) ban nontobacco e-cigarette flavors as a response to increased reports of serious respiratory illness linked to vaping. Here, the consumer product liability attorneys at The Law Offices of Peter Angelos discuss this breaking news.   Potential Vaping-Related Lung Illnesses Cause Nationwide Concern As…

Read More...